Showing results (261-270 of 425) with videos related to

Sort By:
Pageof 43
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2025
Developing digital health technologies for frontotemporal degenerationNaomi Nevler, Debra Niehoff, Amanda M Gleixner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 15, 2024
Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementiasElena Tsoy, Renaud La Joie, Lawren VandeVrede, et al.
Frontiers in Neurology|April 11, 2024
Sensitivity of the African neuropsychology battery memory subtests and learning slopes in discriminating APOE 4 and amyloid pathology in adult individuals in the Democratic Republic of CongoJean Ikanga, Sarah D Patrick, Megan Schwinne, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Neurodegenerative Plasma Biomarkers for Prediction of Hippocampal Atrophy in Older Adults with Suspected Alzheimer's Disease in Kinshasa, Democratic Republic of CongoJean Ikanga, Kharine Jean, Priscilla Medina, et al.
Neurology|December 29, 2017
Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sampleRenaud La Joie, Alexandre Bejanin, Anne M Fagan, et al.
JAMA|October 17, 2018
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative DisordersRik Ossenkoppele, Gil D Rabinovici, Ruben Smith, et al.
The Lancet. Neurology|January 8, 2013
Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trialAdam L Boxer, David S Knopman, Daniel I Kaufer, et al.
Annals of Clinical and Translational Neurology|October 24, 2018
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectoryPeter A Ljubenkov, Adam M Staffaroni, Julio C Rojas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 8, 2025
Combining plasma neurofilament light chain and frontotemporal atrophy improves differentiation of bvFTD from primary psychiatric disordersSean Coulborn, Ashlin R K Roy, Andrzej Sokolowski, et al.
Neurology|December 20, 2013
Practical utility of amyloid and FDG-PET in an academic dementia centerPascual Sánchez-Juan, Pia M Ghosh, Jayne Hagen, et al.
Pageof 43